Pfizer-BioNTech COVID-19 vaccine outperforms Sinovac jab in antibody study 02-Aug-2021 By Nick Taylor The mRNA vaccine developed by Pfizer and BioNTech generates far higher levels of antibodies against the coronavirus than Sinovac’s inactivated virus prophylactic, according to a study.